i

2017 - 2022 (Global competitiveness and innovation in health)


Results 1 - 25 of 48
Public Name Status Date Registered
A 12-week, multicenter, randomized, double-blind, placebo-controlled study to assess the efficacy and safety of QAW039 when added to standard-of-care asthma therapy in patients with uncontrolled asthm . . .
PHRR180320-001820
Completed 20 Mar 2018
A 12-week double-blind, randomized, multi-center study comparing the efficacy and safety of once monthly subcutaneous AMG 334 against placebo in adult episodic migraine patients (EMPOwER) . . .
PHRR180405-001821
Completed 05 Apr 2018
A Phase 3, Multi-center, Randomized, Double-Masked Study to Evaluate the Clinical Efficacy and Safety of SHP640 (PVP-Iodine 0.6% and Dexamethasone 0.1%) Ophthalmic Suspension Compared to PVP-Iodine an . . .
PHRR180425-001827
Terminated 25 Apr 2018
A Phase III, Randomized, Placebo-controlled, Double-blind, Multi-center, International Study of Durvalumab Given Concurrently with Platinum-based Chemoradiation Therapy in Patients with Locally Advanc . . .
PHRR180601-001840
Ongoing 01 Jun 2018
Trial of faropenem and cefadroxil (in combination with amoxicillin/clavulanic acid and standard TB drugs) in patients with pulmonary tuberculosis . . .
PHRR181108-001980
Ongoing 08 Nov 2018
A Phase III, Randomized, Open-Label, Controlled, Multi-Center, Global Study of First-Line Durvalumab in Combination with Standard of Care Chemotherapy and Durvalumab in Combination with Tremelimumab a . . .
PHRR190110-001981
Ongoing 10 Jan 2019
A Phase III, Randomised, Double-Blind, Placebo-Controlled, Multicenter, Study of Durvalumab as Consolidation Therapy in Patients with Locally Advanced, Unresectable, Non-Small Cell Lung Cancer (Stage . . .
PHRR190110-001991
Ongoing 10 Jan 2019
A Phase III, Randomized, Open-Label, Multi-Center, Global Study to Determine the Efficacy and Safety of Durvalumab in Combination with Gemcitabine + Cisplatin for Neoadjuvant Treatment Followed by Dur . . .
PHRR190201-002062
Ongoing 01 Feb 2019
A Phase III, Double-blind, Placebo-controlled, Multi-center International Study of Neoadjuvant/Adjuvant Durvalumab for the Treatment of Patients with Resectable Stages II and III Non-small Cell Lung C . . .
PHRR190321-002089
Ongoing 21 Mar 2019
A Phase 2a Open-Label Study in Infants with REspiratory Syncytial VIRus Lower RespirAtory Tract Infection, Followed by a DoubLe-blind, Placebo-controlled Part, to Evaluate the Safety, Tolerability, Ph . . .
PHRR190424-002103
Terminated 24 Apr 2019
A Phase III, Randomized, Multi-Center, Double-Blind, Global Study to Determine the Efficacy and Safety of Durvalumab in Combination With and following Chemoradiotherapy Compared to Chemoradiotherapy A . . .
PHRR190424-002106
Ongoing 24 Apr 2019
A Phase III Double-blind Randomised Study Assessing the Efficacy and Safety of Capivasertib + Paclitaxel Versus Placebo + Paclitaxel as First-line Treatment for Patients with Histologically Confirmed, . . .
PHRR190620-002157
Ongoing 20 Jun 2019
Application of Stem Cells for Diabetic Foot Wounds
PHRR190709-002163
Ongoing 09 Jul 2019
A Regional, Multicentre, Randomized, Double-Blind, Placebo Controlled, Parallel Group, Phase 3 Study to Evaluate the Efficacy and Safety of Tezepelumab in Adults with Severe Uncontrolled Asthma . . .
PHRR190725-002167
Ongoing 25 Jul 2019
Ertugliflozin Type 2 Diabetes Mellitus (T2DM) Pediatric Study (MK8835/PF-04971729) (MK-8835-059)
PHRR190913-002184
Ongoing 13 Sep 2019
A Multicenter, Randomized, Double-blind, Chronic-dosing, Parallel-group, Placebo-controlled Phase 3 Study to Evaluate the Efficacy and Safety of Benralizumab 100 mg in Patients with Moderate to Very S . . .
PHRR190918-002196
Ongoing 18 Sep 2019
A randomized, double-blind, controlled study on the safety and efficacy of 25% Tinospora rumphii (Makabuhay) cream versus 2% mupirocin cream on superficial pyodermas caused by Staphylococcus aureus . . .
PHRR191025-002228
Completed 25 Oct 2019
Hydrogen Peroxide 3% Solution as Treatment for Molluscum Contagiosum: A Pilot Study
PHRR200110-002396
Completed 10 Jan 2020
Anti-Cancer Study of Medicinal Plants from Region XII
PHRR200202-002478
Ongoing 02 Feb 2020
Study of cefiderocol or standard of care for paediatric patients with confirmed or suspected Gram-negative bacterial infections receiving a single dose and paediatric patients with confirmed or suspec . . .
PHRR200302-002484
Ongoing 02 Mar 2020
Evaluation of Pharmacokinetics, Safety, and Tolerability of Ceftazidime-avibactam in Neonates and Infants . . .
PHRR200226-002498
Ongoing 26 Feb 2020
A Randomized, Multicenter, Open-Label, Phase 3 Study to Evaluate the Efficacy and Safety of Acalabrutinib versus Chlorambucil plus Rituximab in Subjects with Previously Untreated Chronic Lymphocytic L . . .
PHRR200403-002584
Pending 03 Apr 2020
A RANDOMIZED OPEN LABEL PHASE 2B/3 STUDY OF THE SAFETY AND EFFICACY OF NP-120 (IFENPRODIL) FOR THE TREATMENT OF HOSPITALIZED PATIENTS WITH CONFIRMED COVID 19 DISEASE . . .
PHRR200812-002818
Terminated 12 Aug 2020
A Multicenter, Open-label, Phase III Extension Trial to Study the Long-term Safety and Efficacy in Participants with Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab T . . .
PHRR210209-002881
Ongoing 09 Feb 2021
PHASE 1,STUDY TO ASSESS THE PHARMACOKINETICS, SAFETY AND TOLERABILITY OF CEFTAZIDIMEAVIBACTAM (CAZ-AVI) IN CHILDREN FROM 3 MONTHS TO LESS THAN 18 YEARS OF AGE WHO ARE HOSPITALIZED AND RECEIVING SYSTE . . .
PHRR200909-002908
Ongoing 09 Sep 2020
©2022 HERDIN PLUS. All rights reserved. | Contact Us | Keep up to date